[
  {
    "title": "康华生物(300841.SZ)：平潭盈科方面累计减持1%股份",
    "href": "http://stock.jrj.com.cn/2023/01/06163237264412.shtml",
    "datetime": "2023-01-06 16:32:30",
    "code": "300841"
  },
  {
    "title": "A股异动 | 康华生物(300841.SZ)大跌逾9% 重要股东拟合计减持不超6%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/14101337211073.shtml",
    "datetime": "2022-12-14 10:13:46",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科及其一致行动人拟合计减持不超6%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/13200737209994.shtml",
    "datetime": "2022-12-13 20:07:37",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：高管吴文年拟减持不超6.416万股",
    "href": "http://stock.jrj.com.cn/2022/12/13200637209997.shtml",
    "datetime": "2022-12-13 20:06:54",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：李声友拟减持不超3.31万股",
    "href": "http://stock.jrj.com.cn/2022/11/08182737121291.shtml",
    "datetime": "2022-11-08 18:27:18",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：3名董事、高管减持数过半 已合计减持7.965万股",
    "href": "http://stock.jrj.com.cn/2022/11/07174937117693.shtml",
    "datetime": "2022-11-07 17:49:04",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：蔡勇提前终止减持计划、已累计减持2.15%的股份",
    "href": "http://stock.jrj.com.cn/2022/11/03202037110947.shtml",
    "datetime": "2022-11-03 20:20:58",
    "code": "300841"
  },
  {
    "title": "康华生物2022年前三季度净利4.83亿同比下滑17.15% 研发投入持续增加",
    "href": "http://stock.jrj.com.cn/2022/10/24225037079939.shtml",
    "datetime": "2022-10-24 22:50:52",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)三季度净利1.68亿元 同比下降49.38%",
    "href": "http://stock.jrj.com.cn/2022/10/24181737078729.shtml",
    "datetime": "2022-10-24 18:17:18",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科及泰格盈科自7月4日起已累计减持共1%股份",
    "href": "http://stock.jrj.com.cn/2022/09/28200537028935.shtml",
    "datetime": "2022-09-28 20:05:18",
    "code": "300841"
  },
  {
    "title": "康华生物：已完成对厂房设施等升级更新 9月19日恢复生产",
    "href": "http://stock.jrj.com.cn/2022/09/18163337002646.shtml",
    "datetime": "2022-09-18 16:33:22",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)已完成对厂房设施、设备升级更新并恢复生产",
    "href": "http://stock.jrj.com.cn/2022/09/18160237002621.shtml",
    "datetime": "2022-09-18 16:02:15",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：股东蔡勇减持比例达到1%",
    "href": "http://stock.jrj.com.cn/2022/09/13183636991923.shtml",
    "datetime": "2022-09-13 18:36:24",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)截至8月底已累计回购0.61%的股份",
    "href": "http://stock.jrj.com.cn/2022/09/01201236964154.shtml",
    "datetime": "2022-09-01 20:12:25",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：股东蔡勇已合计减持1.15%的股份",
    "href": "http://stock.jrj.com.cn/2022/08/22212036923177.shtml",
    "datetime": "2022-08-22 21:20:35",
    "code": "300841"
  },
  {
    "title": "康华生物披露2022年半年报 实现营收6.60亿元",
    "href": "http://stock.jrj.com.cn/2022/08/22180036922304.shtml",
    "datetime": "2022-08-22 18:00:15",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)半年度净利润3.16亿元 同比增长25.18%",
    "href": "http://stock.jrj.com.cn/2022/08/22164836921759.shtml",
    "datetime": "2022-08-22 16:48:08",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科方面减持期过半 合计减持226.72万股",
    "href": "http://stock.jrj.com.cn/2022/08/18184736913125.shtml",
    "datetime": "2022-08-18 18:47:14",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：减持完毕 股东钟泽荣已减持6.66万股",
    "href": "http://stock.jrj.com.cn/2022/08/03180636867475.shtml",
    "datetime": "2022-08-03 18:06:45",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：已累计耗资约1.16亿元回购82.5万股",
    "href": "http://stock.jrj.com.cn/2022/08/02190836863800.shtml",
    "datetime": "2022-08-02 19:08:35",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：部分董事、高管及其他股东拟合计减持不超29.7098万股",
    "href": "http://stock.jrj.com.cn/2022/07/18165636821567.shtml",
    "datetime": "2022-07-18 16:56:16",
    "code": "300841"
  },
  {
    "title": "康华生物2022年上半年预计净利3.08亿-3.3亿 同比增加22%-31%自主疫苗产品销售收入增加",
    "href": "http://stock.jrj.com.cn/2022/07/15231036817650.shtml",
    "datetime": "2022-07-15 23:10:50",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)半年度净利润预增22.14%-30.86%",
    "href": "http://stock.jrj.com.cn/2022/07/15200236817154.shtml",
    "datetime": "2022-07-15 20:02:14",
    "code": "300841"
  },
  {
    "title": "康华生物：上半年净利预增22.14％-30.86％",
    "href": "http://stock.jrj.com.cn/2022/07/15200136817110.shtml",
    "datetime": "2022-07-15 20:01:30",
    "code": "300841"
  },
  {
    "title": "康华生物：产品单一 减持凶猛",
    "href": "http://stock.jrj.com.cn/2022/07/12165436803663.shtml",
    "datetime": "2022-07-12 16:54:20",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：车间预防性维护保养及水系统升级停产",
    "href": "http://stock.jrj.com.cn/2022/07/06181936787814.shtml",
    "datetime": "2022-07-06 18:19:08",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)截至6月底已累计回购0.61%的股份",
    "href": "http://stock.jrj.com.cn/2022/07/04201236781140.shtml",
    "datetime": "2022-07-04 20:12:33",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科方面减持比例达到1%",
    "href": "http://stock.jrj.com.cn/2022/07/01183636776075.shtml",
    "datetime": "2022-07-01 18:36:13",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科、泰格盈科累计减持1%股份",
    "href": "http://stock.jrj.com.cn/2022/06/17200036739247.shtml",
    "datetime": "2022-06-17 20:00:35",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)截至5月底已累计回购81.6万股",
    "href": "http://stock.jrj.com.cn/2022/06/02180036701229.shtml",
    "datetime": "2022-06-02 18:00:43",
    "code": "300841"
  },
  {
    "title": "康华生物股东蔡勇减持92.21万股 套现约8552.48万 2021年公司净利8.29亿",
    "href": "http://stock.jrj.com.cn/2022/05/30201136690830.shtml",
    "datetime": "2022-05-30 20:11:19",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：2021年年度权益分派10转5派15元 股权登记日5月24日",
    "href": "http://stock.jrj.com.cn/2022/05/18201336659993.shtml",
    "datetime": "2022-05-18 20:13:10",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：高管吴文年完成增持1.75万股",
    "href": "http://stock.jrj.com.cn/2022/05/16201436652669.shtml",
    "datetime": "2022-05-16 20:14:29",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：拟要求相关股东回购公司所持广西爱宠股份",
    "href": "http://stock.jrj.com.cn/2022/05/08195036598162.shtml",
    "datetime": "2022-05-08 19:50:44",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)截至4月底已累计回购0.91%的股份",
    "href": "http://stock.jrj.com.cn/2022/05/06193636582487.shtml",
    "datetime": "2022-05-06 19:36:32",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：核心技术人员赵志鹏离职",
    "href": "http://stock.jrj.com.cn/2022/05/06193236582492.shtml",
    "datetime": "2022-05-06 19:32:11",
    "code": "300841"
  },
  {
    "title": "康华生物2022年第一季度净利1.35亿同比增长34.6% 收到政府补助",
    "href": "http://stock.jrj.com.cn/2022/04/24133036445672.shtml",
    "datetime": "2022-04-24 13:30:20",
    "code": "300841"
  },
  {
    "title": "康华生物2021年净利8.29亿同比增长103.28% 董事长王振滔薪酬72万",
    "href": "http://stock.jrj.com.cn/2022/04/22195136431082.shtml",
    "datetime": "2022-04-22 19:51:26",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科及泰格盈科拟合计减持不超5%的股份",
    "href": "http://stock.jrj.com.cn/2022/04/22150836428101.shtml",
    "datetime": "2022-04-22 15:08:39",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)一季度净利润1.35亿元 同比增长34.60%",
    "href": "http://stock.jrj.com.cn/2022/04/21200236421522.shtml",
    "datetime": "2022-04-21 20:02:37",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)2021年度净利润升103.28%至8.29亿元 拟10转5派15元",
    "href": "http://stock.jrj.com.cn/2022/04/21200036421525.shtml",
    "datetime": "2022-04-21 20:00:47",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：截至3月底已累计回购36万股",
    "href": "http://stock.jrj.com.cn/2022/04/01195936248573.shtml",
    "datetime": "2022-04-01 19:59:05",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：含7名董监高在内共23人拟合计减持不超63.34万股",
    "href": "http://stock.jrj.com.cn/2022/03/25210635153003.shtml",
    "datetime": "2022-03-25 21:06:40",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：截至2月底已累计回购33.4万股",
    "href": "http://stock.jrj.com.cn/2022/03/02183934513074.shtml",
    "datetime": "2022-03-02 18:39:22",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：冻干人用狂犬病疫苗(人二倍体细胞)获得药品再注册批准通知书",
    "href": "http://stock.jrj.com.cn/2022/02/16174934370375.shtml",
    "datetime": "2022-02-16 17:49:04",
    "code": "300841"
  },
  {
    "title": "康华生物2名股东合计减持487.9万股 套现合计8.74亿 2021年公司净利8.08亿-8.4亿",
    "href": "http://stock.jrj.com.cn/2022/02/11211034326654.shtml",
    "datetime": "2022-02-11 21:10:56",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：减持期届满 平潭盈科、泰格盈科已合计减持487.9万股",
    "href": "http://stock.jrj.com.cn/2022/02/11184834324488.shtml",
    "datetime": "2022-02-11 18:48:26",
    "code": "300841"
  },
  {
    "title": "康华生物股东蔡勇减持227.8万股 套现4.63亿 2021年公司净利8.08亿-8.4亿",
    "href": "http://stock.jrj.com.cn/2022/02/09213134314782.shtml",
    "datetime": "2022-02-09 21:31:53",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：股东蔡勇完成减持227.8万股",
    "href": "http://stock.jrj.com.cn/2022/02/09190234314327.shtml",
    "datetime": "2022-02-09 19:02:47",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：截至1月底已累计回购33.4万股",
    "href": "http://stock.jrj.com.cn/2022/02/09190034314324.shtml",
    "datetime": "2022-02-09 19:00:36",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科、泰格盈科已累计减持1%的股份",
    "href": "http://stock.jrj.com.cn/2022/01/28204534248584.shtml",
    "datetime": "2022-01-28 20:45:03",
    "code": "300841"
  },
  {
    "title": "A股异动丨康华生物(300841.SZ)盘中大涨13% 2021年净利预增翻倍",
    "href": "http://stock.jrj.com.cn/2022/01/25100234208652.shtml",
    "datetime": "2022-01-25 10:02:42",
    "code": "300841"
  },
  {
    "title": "A股异动 | 康华生物涨近12% 2021年度净利润预增98.02%-105.86%",
    "href": "http://stock.jrj.com.cn/2022/01/25095534208628.shtml",
    "datetime": "2022-01-25 09:55:41",
    "code": "300841"
  },
  {
    "title": "康华生物2021年预计净利8.08亿-8.4亿同比增长98%-106% 公司实行精细化管理费用下降",
    "href": "http://stock.jrj.com.cn/2022/01/25051234207772.shtml",
    "datetime": "2022-01-25 05:12:06",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)2021年度净利润预增98.02%-105.86%",
    "href": "http://stock.jrj.com.cn/2022/01/24195234206094.shtml",
    "datetime": "2022-01-24 19:52:14",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：股东蔡勇减持比例达到1%",
    "href": "http://stock.jrj.com.cn/2022/01/06171134129964.shtml",
    "datetime": "2022-01-06 17:11:13",
    "code": "300841"
  },
  {
    "title": "康华生物2名股东合计减持89.77万股 套现合计约1.52亿 第三季度公司净利3.31亿",
    "href": "http://stock.jrj.com.cn/2021/12/13215334010925.shtml",
    "datetime": "2021-12-13 21:53:03",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科、泰格盈科已合计减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/12/13181134009543.shtml",
    "datetime": "2021-12-13 18:11:42",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：截至11月底累计耗资3921.84万元回购0.26%股份",
    "href": "http://stock.jrj.com.cn/2021/12/01172933950422.shtml",
    "datetime": "2021-12-01 17:29:41",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科、泰格盈科近期共减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/11/25162933919095.shtml",
    "datetime": "2021-11-25 16:29:11",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：与信然博创就基于mRNA技术平台研究开发带状疱疹疫苗、肺结核疫苗和狂犬疫苗达成合作",
    "href": "http://stock.jrj.com.cn/2021/11/23154633909500.shtml",
    "datetime": "2021-11-23 15:46:46",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：与信然博创就利用mRNA技术平台共同开展针对传染性疾病的疫苗研究达成战略合作",
    "href": "http://stock.jrj.com.cn/2021/11/18200133874084.shtml",
    "datetime": "2021-11-18 20:01:03",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：3名股东减持期过半 合计减持301.14万股",
    "href": "http://stock.jrj.com.cn/2021/11/11155333836444.shtml",
    "datetime": "2021-11-11 15:53:39",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：11月4日首次回购5100股",
    "href": "http://stock.jrj.com.cn/2021/11/05173033817371.shtml",
    "datetime": "2021-11-05 17:30:00",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)第三季度扣非净利润9993.15万元 同比下降37.74%",
    "href": "http://stock.jrj.com.cn/2021/10/25211333750047.shtml",
    "datetime": "2021-10-25 21:13:42",
    "code": "300841"
  },
  {
    "title": "康华生物股东淄博泰格盈超额减持 被出具监管函",
    "href": "http://stock.jrj.com.cn/2021/10/22165833733958.shtml",
    "datetime": "2021-10-22 16:58:34",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：泰格盈科就超额减持一事致歉",
    "href": "http://stock.jrj.com.cn/2021/10/19180433717419.shtml",
    "datetime": "2021-10-19 18:04:08",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：股东蔡勇已减持1.03%的股份",
    "href": "http://stock.jrj.com.cn/2021/10/13181333685837.shtml",
    "datetime": "2021-10-13 18:13:53",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科、泰格盈科已累计减持1.04%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/29222533538754.shtml",
    "datetime": "2021-09-29 22:25:15",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：子公司签下杭州佑本宠物产品宠物狂犬病灭活疫苗中国全渠道总经销商",
    "href": "http://stock.jrj.com.cn/2021/09/22115533498064.shtml",
    "datetime": "2021-09-22 11:55:43",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：平潭盈科、泰格盈科已累计减持1.04%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/16201033446698.shtml",
    "datetime": "2021-09-16 20:10:30",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：三明广隶不再拥有公司股份",
    "href": "http://stock.jrj.com.cn/2021/09/09203433411132.shtml",
    "datetime": "2021-09-09 20:34:16",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：三明广隶已减持42.5635万股、其决定提前终止减持计划",
    "href": "http://stock.jrj.com.cn/2021/09/01205333369538.shtml",
    "datetime": "2021-09-01 20:53:35",
    "code": "300841"
  },
  {
    "title": "康华生物2021年上半年净利2.52亿增长38.03% 疫苗产品销量增加",
    "href": "http://stock.jrj.com.cn/2021/08/02221533191060.shtml",
    "datetime": "2021-08-02 22:15:20",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)半年度净利润升38.03%至2.52亿元",
    "href": "http://stock.jrj.com.cn/2021/08/02194433190394.shtml",
    "datetime": "2021-08-02 19:44:00",
    "code": "300841"
  },
  {
    "title": "康华生物上市一年股价“过山车” 股东减持14亿市值距高点蒸发400亿",
    "href": "http://stock.jrj.com.cn/2021/07/30081133173616.shtml",
    "datetime": "2021-07-30 08:11:37",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：持股5%以上的若干股东拟合计减持不超9.8084%的股份",
    "href": "http://stock.jrj.com.cn/2021/07/20224333126490.shtml",
    "datetime": "2021-07-20 22:43:48",
    "code": "300841"
  },
  {
    "title": "康华生物聘任王清瀚为总经理",
    "href": "http://stock.jrj.com.cn/2021/07/16212633109400.shtml",
    "datetime": "2021-07-16 21:26:12",
    "code": "300841"
  },
  {
    "title": "康华生物2021年上半年预计净利2.44亿-2.55亿增长34%-40% 产品销量与价格提升",
    "href": "http://stock.jrj.com.cn/2021/07/15201233103403.shtml",
    "datetime": "2021-07-15 20:12:28",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)上半年预盈2.44亿元-2.55亿元 同比增长33.56%-39.58%",
    "href": "http://stock.jrj.com.cn/2021/07/15170633102247.shtml",
    "datetime": "2021-07-15 17:06:19",
    "code": "300841"
  },
  {
    "title": "康华生物：公司人二倍体固定化生物反应器培养工艺项目系为提高现有生产能力的在研项目",
    "href": "http://stock.jrj.com.cn/2021/06/21225832972188.shtml",
    "datetime": "2021-06-21 22:58:10",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：持股5%以上的平潭盈科盛道解押384万股",
    "href": "http://stock.jrj.com.cn/2021/06/17211032949757.shtml",
    "datetime": "2021-06-17 21:10:18",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：4062.66万股首发原股东限售股待解禁 实际可上市流通数量为2511.02万股",
    "href": "http://stock.jrj.com.cn/2021/06/10190232906510.shtml",
    "datetime": "2021-06-10 19:02:59",
    "code": "300841"
  },
  {
    "title": "康华生物：康泰生物二倍体狂苗的上市对公司总体影响有限",
    "href": "http://stock.jrj.com.cn/2021/06/08070732890617.shtml",
    "datetime": "2021-06-08 07:07:38",
    "code": "300841"
  },
  {
    "title": "康华生物：公司脑膜炎疫苗目前的产能为100万支",
    "href": "http://stock.jrj.com.cn/2021/06/07224632889340.shtml",
    "datetime": "2021-06-07 22:46:35",
    "code": "300841"
  },
  {
    "title": "康华生物：2018年度存在部分产品不予放行 导致库存商品减少 期末余额同比减少",
    "href": "http://stock.jrj.com.cn/2021/06/07184832887964.shtml",
    "datetime": "2021-06-07 18:48:59",
    "code": "300841"
  },
  {
    "title": "康华生物：股权激励的目标基础主要来源公司狂苗一车间持续稳定的生产并投放市场等原因",
    "href": "http://stock.jrj.com.cn/2021/06/07071332885163.shtml",
    "datetime": "2021-06-07 07:13:42",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：奥康集团质押并解除质押399万股",
    "href": "http://stock.jrj.com.cn/2021/06/03185732870380.shtml",
    "datetime": "2021-06-03 18:57:28",
    "code": "300841"
  },
  {
    "title": "康华生物：实际控制人一致行动人部分股权质押及解除质押",
    "href": "http://stock.jrj.com.cn/2021/06/03173032869986.shtml",
    "datetime": "2021-06-03 17:30:09",
    "code": "300841"
  },
  {
    "title": "康华生物：公司没有退出对艾博生物的投资",
    "href": "http://stock.jrj.com.cn/2021/06/02185632864802.shtml",
    "datetime": "2021-06-02 18:56:18",
    "code": "300841"
  },
  {
    "title": "康华生物：二车间自公司取得《药品生产许可证》之日起就可正式投产",
    "href": "http://stock.jrj.com.cn/2021/05/31161832850194.shtml",
    "datetime": "2021-05-31 16:18:09",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：公司病毒性疫苗二车间通过药品GMP符合性检查并完成《药品生产许可证》变更",
    "href": "http://stock.jrj.com.cn/2021/05/30174932841354.shtml",
    "datetime": "2021-05-30 17:49:11",
    "code": "300841"
  },
  {
    "title": "康华生物(300841)：2020年年度权益分派实施，每10股派发现金红利15.0元（含税）",
    "href": "http://stock.jrj.com.cn/2021/05/20202832789885.shtml",
    "datetime": "2021-05-20 20:28:24",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：2020年度拟10派15元 5月26日股权登记",
    "href": "http://stock.jrj.com.cn/2021/05/20202032788993.shtml",
    "datetime": "2021-05-20 20:20:09",
    "code": "300841"
  },
  {
    "title": "康华生物：公司正在积极推进二车间技改事宜",
    "href": "http://stock.jrj.com.cn/2021/05/13100032746797.shtml",
    "datetime": "2021-05-13 10:00:51",
    "code": "300841"
  },
  {
    "title": "康华生物：二车间正式投产时间尚难以准确预计 目前处于《药品生产许可证》变更程序之中",
    "href": "http://stock.jrj.com.cn/2021/05/10130232728346.shtml",
    "datetime": "2021-05-10 13:02:31",
    "code": "300841"
  },
  {
    "title": "康华生物上市10个月股价涨5.48倍 王宝桐隐秘入股三年获利2.8亿",
    "href": "http://stock.jrj.com.cn/2021/04/27071832461073.shtml",
    "datetime": "2021-04-27 07:18:20",
    "code": "300841"
  },
  {
    "title": "康华生物：公司整体生产经营比较平稳",
    "href": "http://stock.jrj.com.cn/2021/04/22154032423219.shtml",
    "datetime": "2021-04-22 15:40:58",
    "code": "300841"
  },
  {
    "title": "康华生物：公司持有其股权比例将由原10.00%变更为 8.00%",
    "href": "http://stock.jrj.com.cn/2021/04/22150432423068.shtml",
    "datetime": "2021-04-22 15:04:38",
    "code": "300841"
  },
  {
    "title": "康华生物：公司二车间技改事宜目前处于《药品生产许可证》变更程序之中",
    "href": "http://stock.jrj.com.cn/2021/04/22145132422977.shtml",
    "datetime": "2021-04-22 14:51:42",
    "code": "300841"
  },
  {
    "title": "康华生物 高增长背后有隐忧",
    "href": "http://stock.jrj.com.cn/2021/04/21073332413871.shtml",
    "datetime": "2021-04-21 07:33:16",
    "code": "300841"
  },
  {
    "title": "康华生物2021年第一季度净利增长54.91% 销量增加",
    "href": "http://stock.jrj.com.cn/2021/04/20230632412528.shtml",
    "datetime": "2021-04-20 23:06:56",
    "code": "300841"
  },
  {
    "title": "康华生物去年净利增87% 一季度十大流通股东9家减持",
    "href": "http://stock.jrj.com.cn/2021/04/20163632410262.shtml",
    "datetime": "2021-04-20 16:36:00",
    "code": "300841"
  },
  {
    "title": "康华生物2020年净利增长118.57% 董事长王振滔薪酬72万",
    "href": "http://stock.jrj.com.cn/2021/04/20134632409188.shtml",
    "datetime": "2021-04-20 13:46:42",
    "code": "300841"
  },
  {
    "title": "A股异动丨康华生物(300841.SZ)涨近6% 一季度净利升54.91%至1亿元",
    "href": "http://stock.jrj.com.cn/2021/04/20101532408122.shtml",
    "datetime": "2021-04-20 10:15:58",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)一季度净利升54.91%至1.00亿元",
    "href": "http://stock.jrj.com.cn/2021/04/19230032404832.shtml",
    "datetime": "2021-04-19 23:00:40",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)2020年净利升118.57%至4.08亿元 拟10转5派15元",
    "href": "http://stock.jrj.com.cn/2021/04/19225732404826.shtml",
    "datetime": "2021-04-19 22:57:49",
    "code": "300841"
  },
  {
    "title": "康华生物：公司未直接投资参与苏州艾博生物科技有限公司B轮融资",
    "href": "http://stock.jrj.com.cn/2021/04/12133932357256.shtml",
    "datetime": "2021-04-12 13:39:00",
    "code": "300841"
  },
  {
    "title": "康华生物HIV抗体系列检测试剂再获认可 今日盘中大涨超7%",
    "href": "http://stock.jrj.com.cn/2021/04/08114832331075.shtml",
    "datetime": "2021-04-08 11:48:34",
    "code": "300841"
  },
  {
    "title": "康华生物：公司目前的批签发情况与修订药品说明书及重新制作包装标签无关",
    "href": "http://stock.jrj.com.cn/2021/03/31110132254525.shtml",
    "datetime": "2021-03-31 11:01:40",
    "code": "300841"
  },
  {
    "title": "康华生物：公司目前生产经营情况一切正常",
    "href": "http://stock.jrj.com.cn/2021/03/31105132254419.shtml",
    "datetime": "2021-03-31 10:51:25",
    "code": "300841"
  },
  {
    "title": "康华生物：公司的资金主要用于募投项目的建设及为产品管线布局而开展的研发项目",
    "href": "http://stock.jrj.com.cn/2021/03/16092632142869.shtml",
    "datetime": "2021-03-16 09:26:17",
    "code": "300841"
  },
  {
    "title": "康华生物：公司二车间投产事宜目前处于符合性检测阶段",
    "href": "http://stock.jrj.com.cn/2021/03/08150332091007.shtml",
    "datetime": "2021-03-08 15:03:25",
    "code": "300841"
  },
  {
    "title": "超9成销售收入来自核心产品 康华生物欲斥资4000万涉入新领域",
    "href": "http://stock.jrj.com.cn/2021/03/02194832058997.shtml",
    "datetime": "2021-03-02 19:48:54",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)拟4125万元增资入股可恩生物",
    "href": "http://stock.jrj.com.cn/2021/03/01204032052426.shtml",
    "datetime": "2021-03-01 20:40:33",
    "code": "300841"
  },
  {
    "title": "康华生物：公司二车间投产前的各方面准备工作已经完成",
    "href": "http://stock.jrj.com.cn/2021/03/01112032048921.shtml",
    "datetime": "2021-03-01 11:20:23",
    "code": "300841"
  },
  {
    "title": "康华生物：公司现在公司病毒性疫苗二车间通过药品生产质量管理规范符合性检查",
    "href": "http://stock.jrj.com.cn/2021/02/25103832024115.shtml",
    "datetime": "2021-02-25 10:38:45",
    "code": "300841"
  },
  {
    "title": "康华生物：公司目前生产经营情况一切正常",
    "href": "http://stock.jrj.com.cn/2021/02/22161932006257.shtml",
    "datetime": "2021-02-22 16:19:25",
    "code": "300841"
  },
  {
    "title": "康华生物能撑起311亿市值吗？",
    "href": "http://stock.jrj.com.cn/2021/01/20234431731860.shtml",
    "datetime": "2021-01-20 23:44:39",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)业绩快报：2020年度净利润升118.57%至4.08亿元",
    "href": "http://stock.jrj.com.cn/2021/01/19201531723768.shtml",
    "datetime": "2021-01-19 20:15:02",
    "code": "300841"
  },
  {
    "title": "康华生物：公司人二倍体500L微载体规模化培养工艺项目属于技术储备",
    "href": "http://stock.jrj.com.cn/2021/01/14092331688803.shtml",
    "datetime": "2021-01-14 09:23:31",
    "code": "300841"
  },
  {
    "title": "康华生物实际控制人之一致行动人奥康集团质押212万股 用于资金周转需要",
    "href": "http://stock.jrj.com.cn/2021/01/11201931672039.shtml",
    "datetime": "2021-01-11 20:19:11",
    "code": "300841"
  },
  {
    "title": "康华生物：二车间技改项目预计年底达到投产状态",
    "href": "http://stock.jrj.com.cn/2020/11/11100231257723.shtml",
    "datetime": "2020-11-11 10:02:39",
    "code": "300841"
  },
  {
    "title": "康华生物：预计2020年度净利润较2019年度增长率超过100%",
    "href": "http://stock.jrj.com.cn/2020/11/05151531221555.shtml",
    "datetime": "2020-11-05 15:15:49",
    "code": "300841"
  },
  {
    "title": "康华生物：公司疫苗产品完工后报送中检院进行批签发",
    "href": "http://stock.jrj.com.cn/2020/10/30095531173599.shtml",
    "datetime": "2020-10-30 09:55:02",
    "code": "300841"
  },
  {
    "title": "山东康华生物启动上市辅导 曾获华润资本等注资",
    "href": "http://stock.jrj.com.cn/ipo/2020/10/28082831147881.shtml",
    "datetime": "2020-10-28 08:28:55",
    "code": "300841"
  },
  {
    "title": "康华生物跌10.5% 近1个月华西证券与中泰证券喊买入",
    "href": "http://stock.jrj.com.cn/2020/10/22161331109100.shtml",
    "datetime": "2020-10-22 16:13:00",
    "code": "300841"
  },
  {
    "title": "康华生物：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/21224031103331.shtml",
    "datetime": "2020-10-21 22:40:02",
    "code": "300841"
  },
  {
    "title": "康华生物：第三季度净利润同比增长4256% 全年净利润预增超108%",
    "href": "http://stock.jrj.com.cn/2020/10/21214731103033.shtml",
    "datetime": "2020-10-21 21:47:00",
    "code": "300841"
  },
  {
    "title": "康华生物实际控制人王振滔质押156万股 用于个人资金周转需要",
    "href": "http://stock.jrj.com.cn/2020/10/13102731041958.shtml",
    "datetime": "2020-10-13 10:27:47",
    "code": "300841"
  },
  {
    "title": "疫苗股午后大幅拉升 万方发展涨停 康华生物领涨 涨幅超13％",
    "href": "http://stock.jrj.com.cn/2020/09/18131630776293.shtml",
    "datetime": "2020-09-18 13:16:05",
    "code": "300841"
  },
  {
    "title": "生物疫苗概念持续拉升 君正集团、博辉创新涨停 康华生物、一心堂等多股大涨",
    "href": "http://stock.jrj.com.cn/2020/09/15135830754710.shtml",
    "datetime": "2020-09-15 13:58:22",
    "code": "300841"
  },
  {
    "title": "康华生物：公司病毒性疫苗二车间目前处于GMP认证样品检验和标准符合阶段",
    "href": "http://stock.jrj.com.cn/2020/09/14220030750039.shtml",
    "datetime": "2020-09-14 22:00:20",
    "code": "300841"
  },
  {
    "title": "康华生物：公司人二倍体狂犬疫苗目前为尽量满足国内的需求 尚未出口国外",
    "href": "http://stock.jrj.com.cn/2020/09/14215430749994.shtml",
    "datetime": "2020-09-14 21:54:03",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：放弃参股公司一曜生物20%股权优先购买权",
    "href": "http://stock.jrj.com.cn/2020/09/10082330719793.shtml",
    "datetime": "2020-09-10 08:23:48",
    "code": "300841"
  },
  {
    "title": "康华生物(300841.SZ)：一曜集团拟转让一曜生物20%股权",
    "href": "http://stock.jrj.com.cn/2020/09/07090330690079.shtml",
    "datetime": "2020-09-07 09:03:27",
    "code": "300841"
  },
  {
    "title": "康华生物：上半年实现净利润1.83亿元 同比增长115.51%",
    "href": "http://stock.jrj.com.cn/2020/08/24191930577814.shtml",
    "datetime": "2020-08-24 19:19:00",
    "code": "300841"
  },
  {
    "title": "奥康国际王振滔：康华生物是做疫苗跨界成功 鞋业依然、永远是“大儿子”",
    "href": "http://stock.jrj.com.cn/2020/08/09131630456453.shtml",
    "datetime": "2020-08-09 13:16:53",
    "code": "300841"
  },
  {
    "title": "大肉签康华生物继续大跌！温州“卖鞋王”身价暴涨13倍 昔日销售过期疫苗往事被扒出",
    "href": "http://stock.jrj.com.cn/2020/08/07104530448441.shtml",
    "datetime": "2020-08-07 10:45:42",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物8月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/06180330443105.shtml",
    "datetime": "2020-08-06 18:03:15",
    "code": "300841"
  },
  {
    "title": "创业板第一高价股康华生物跌停",
    "href": "http://stock.jrj.com.cn/2020/08/06104330439961.shtml",
    "datetime": "2020-08-06 10:43:19",
    "code": "300841"
  },
  {
    "title": "狂犬疫苗“大肉签”康华生物：研发投入不及销售费用一成，独占地位即将不保",
    "href": "http://stock.jrj.com.cn/2020/08/05095630430026.shtml",
    "datetime": "2020-08-05 09:56:20",
    "code": "300841"
  },
  {
    "title": "33个交易日股价暴涨12.52倍 一签赚44万 中签的投资者称要持有到1200元/股",
    "href": "http://stock.jrj.com.cn/2020/08/04081030420681.shtml",
    "datetime": "2020-08-04 08:10:20",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月31日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/31180330395229.shtml",
    "datetime": "2020-07-31 18:03:21",
    "code": "300841"
  },
  {
    "title": "生物疫苗概念走强 复星医药、康华生物、赛升药业涨停",
    "href": "http://stock.jrj.com.cn/2020/07/27134230354137.shtml",
    "datetime": "2020-07-27 13:42:38",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/23180130325192.shtml",
    "datetime": "2020-07-23 18:01:10",
    "code": "300841"
  },
  {
    "title": "午后疫苗股继续拉升 康华生物、复星医药等多股涨停",
    "href": "http://stock.jrj.com.cn/2020/07/23131930322767.shtml",
    "datetime": "2020-07-23 13:19:26",
    "code": "300841"
  },
  {
    "title": "生物疫苗板块走强 康华生物、海利生物、海正药业涨停",
    "href": "http://stock.jrj.com.cn/2020/07/22101830312407.shtml",
    "datetime": "2020-07-22 10:18:05",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/21180230305980.shtml",
    "datetime": "2020-07-21 18:02:20",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/20180330294214.shtml",
    "datetime": "2020-07-20 18:03:32",
    "code": "300841"
  },
  {
    "title": "龙虎榜：章盟主接盘机构 溧阳路割肉离场",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/20171530293915.shtml",
    "datetime": "2020-07-20 17:15:28",
    "code": "300841"
  },
  {
    "title": "大肉签新股又来！本周12只齐发，这个有望赚超10万，刚有一签赚29万",
    "href": "http://stock.jrj.com.cn/2020/07/19213530282679.shtml",
    "datetime": "2020-07-19 21:35:40",
    "code": "300841"
  },
  {
    "title": "券商板块花式跳水 康华生物开启造富神话",
    "href": "http://stock.jrj.com.cn/2020/07/18114030279220.shtml",
    "datetime": "2020-07-18 11:40:58",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/17180230275462.shtml",
    "datetime": "2020-07-17 18:02:52",
    "code": "300841"
  },
  {
    "title": "“最赚钱新股”开板首日闪崩跌停！游资却爆买8亿高位接盘",
    "href": "http://stock.jrj.com.cn/2020/07/17065230266662.shtml",
    "datetime": "2020-07-17 06:52:00",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月16日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/16180230262842.shtml",
    "datetime": "2020-07-16 18:02:11",
    "code": "300841"
  },
  {
    "title": "跌停！康华生物上市满月开板跌停 股价涨7倍市值突破300亿",
    "href": "http://stock.jrj.com.cn/2020/07/16134030260523.shtml",
    "datetime": "2020-07-16 13:40:18",
    "code": "300841"
  },
  {
    "title": "次新股板块走弱 康华生物、甘李药业在开板首日即遭跌停",
    "href": "http://stock.jrj.com.cn/2020/07/16094930258375.shtml",
    "datetime": "2020-07-16 09:49:22",
    "code": "300841"
  },
  {
    "title": "康华生物暴涨近两倍 泸州老窖升逾七成",
    "href": "http://stock.jrj.com.cn/2020/07/16010530254193.shtml",
    "datetime": "2020-07-16 01:05:52",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/14180330240111.shtml",
    "datetime": "2020-07-14 18:03:22",
    "code": "300841"
  },
  {
    "title": "1签赚20万还没开板！这只新股太豪横，年内最强打新周也来了，罕见15只新股齐发",
    "href": "http://stock.jrj.com.cn/2020/07/12221030214093.shtml",
    "datetime": "2020-07-12 22:10:45",
    "code": "300841"
  },
  {
    "title": "康华生物上市后连拉15个“一字板” “温州鞋王”身价大增逾50亿",
    "href": "http://stock.jrj.com.cn/2020/07/09234330195261.shtml",
    "datetime": "2020-07-09 23:43:25",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月9日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/09180230193555.shtml",
    "datetime": "2020-07-09 18:02:52",
    "code": "300841"
  },
  {
    "title": "[数说]打新族最强牛市来了！单日暴涨超900%破18年纪录 中一签最多赚近18万 医药股王易主在即！",
    "href": "http://stock.jrj.com.cn/2020/07/09171230193222.shtml",
    "datetime": "2020-07-09 17:12:45",
    "code": "300841"
  },
  {
    "title": "康华生物：上修业绩预告 上半年净利润预增112.33%-118.23%",
    "href": "http://stock.jrj.com.cn/2020/07/08214030182667.shtml",
    "datetime": "2020-07-08 21:40:00",
    "code": "300841"
  },
  {
    "title": "今年最赚钱新股诞生了 这只狂犬疫苗股中一签赚近16万",
    "href": "http://stock.jrj.com.cn/2020/07/08125030178208.shtml",
    "datetime": "2020-07-08 12:50:50",
    "code": "300841"
  },
  {
    "title": "新股康华生物连续15日涨停 中一签盈利超15.7万元",
    "href": "http://stock.jrj.com.cn/2020/07/08100230176432.shtml",
    "datetime": "2020-07-08 10:02:34",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/06180230154977.shtml",
    "datetime": "2020-07-06 18:02:45",
    "code": "300841"
  },
  {
    "title": "【龙虎榜】康华生物7月1日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/01180230112667.shtml",
    "datetime": "2020-07-01 18:02:15",
    "code": "300841"
  },
  {
    "title": "拟2800万元收购一曜生物10%股权 康华生物涨停",
    "href": "http://stock.jrj.com.cn/2020/07/01100930108354.shtml",
    "datetime": "2020-07-01 10:09:52",
    "code": "300841"
  },
  {
    "title": "康华生物：拟2800万元收购一曜生物10%股权 跻身兽用狂犬病疫苗行业",
    "href": "http://stock.jrj.com.cn/2020/06/30220130100683.shtml",
    "datetime": "2020-06-30 22:01:28",
    "code": "300841"
  },
  {
    "title": "北京规范疫情防控常态化期间医疗服务工作 康华生物、奥美医疗等今日涨停 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/06/30181730099170.shtml",
    "datetime": "2020-06-30 18:17:39",
    "code": "300841"
  },
  {
    "title": "疫苗研发好消息，抗体阳转率100％，生物疫苗板块大涨，康华生物涨停",
    "href": "http://stock.jrj.com.cn/2020/06/17104629947809.shtml",
    "datetime": "2020-06-17 10:46:00",
    "code": "300841"
  },
  {
    "title": "西藏药业拟布局新冠疫苗研发 康华生物上市首日涨停 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/06/16182029939641.shtml",
    "datetime": "2020-06-16 18:20:27",
    "code": "300841"
  },
  {
    "title": "康华生物明日上市交易 “鞋王”王振滔跨界疫苗“开花结果”",
    "href": "http://stock.jrj.com.cn/2020/06/15190429929681.shtml",
    "datetime": "2020-06-15 19:04:21",
    "code": "300841"
  },
  {
    "title": "康华生物：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/06/15081129923771.shtml",
    "datetime": "2020-06-15 08:11:15",
    "code": "300841"
  },
  {
    "title": "默沙东、辉瑞等入选美国官方疫苗候选名单 康华生物今日开启申购 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/06/04181529845948.shtml",
    "datetime": "2020-06-04 18:15:15",
    "code": "300841"
  },
  {
    "title": "今日新股申购：康华生物",
    "href": "http://stock.jrj.com.cn/2020/06/04091029841993.shtml",
    "datetime": "2020-06-04 09:10:00",
    "code": "300841"
  },
  {
    "title": "康华生物6月4日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/03143729836036.shtml",
    "datetime": "2020-06-03 14:37:07",
    "code": "300841"
  },
  {
    "title": "康华生物IPO窘境：业绩增长全靠狂犬病疫苗 而该市场增量已到顶",
    "href": "http://stock.jrj.com.cn/2020/03/23073629079898.shtml",
    "datetime": "2020-03-23 07:36:00",
    "code": "300841"
  },
  {
    "title": "康华生物IPO窘境：业绩增长全靠狂犬病疫苗 而该市场增量已到顶",
    "href": "http://stock.jrj.com.cn/2020/03/23073629104311.shtml",
    "datetime": "2020-03-23 07:36:00",
    "code": "300841"
  },
  {
    "title": "康华生物：主打产品获批涉及行贿销售费用逐年增高",
    "href": "http://stock.jrj.com.cn/ipo/2019/08/30175128063483.shtml",
    "datetime": "2019-08-30 17:51:52",
    "code": "300841"
  },
  {
    "title": "背靠奥康闯A股 康华生物存隐忧",
    "href": "http://stock.jrj.com.cn/2019/05/28041427629060.shtml",
    "datetime": "2019-05-28 04:14:46",
    "code": "300841"
  }
]